Inventor
THOMPSON III LORIN A
US22 patents
⚠️ This page may combine multiple inventors who share the name “THOMPSON III LORIN A”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BRISTOL MYERS SQUIBB CO
9 patentsUS7557137B2Jul 7, 2009
Gamma-lactams as beta-secretase inhibitors
BRISTOL MYERS SQUIBB CO9 citations84
US9221796B2Dec 29, 2015
Selective NR2B antagonists
BRISTOL MYERS SQUIBB CO5 citations72
US7902218B2Mar 8, 2011
Substituted tetrahydroisoquinolines as β-secretase inhibitors
BRISTOL MYERS SQUIBB CO5 citations62
US7388007B2Jun 17, 2008
Gamma-lactams as beta-secretase inhibitors
BRISTOL MYERS SQUIBB CO6 citations62
US8349880B2Jan 8, 2013
Bicyclic compounds for the reduction of beta-amyloid production
BRISTOL MYERS SQUIBB CO4 citations61
US7981913B2Jul 19, 2011
Isophthalates as beta-secretase inhibitors
BRISTOL MYERS SQUIBB CO0 citations51
US7745470B2Jun 29, 2010
Isophthalates as beta-secretase inhibitors
BRISTOL MYERS SQUIBB CO0 citations51
US7612069B2Nov 3, 2009
Acyl guanidines as beta-secretase inhibitors
BRISTOL MYERS SQUIBB CO0 citations40
US7601751B2Oct 13, 2009
Indole acetic acid acyl guanidines as β-secretase inhibitors
BRISTOL MYERS SQUIBB CO0 citations37
FULCRUM THERAPEUTICS INC
7 patentsUS10973805B2Apr 13, 2021
Macrocyclic azolopyridine derivatives as EED and PRC2 modulators
FULCRUM THERAPEUTICS INC5 citations81
US11590111B2Feb 28, 2023
Macrocyclic azolopyridine derivatives as EED and PRC2 modulators
FULCRUM THERAPEUTICS INC2 citations70
US10537560B2Jan 21, 2020
P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD
FULCRUM THERAPEUTICS INC4 citations68
US10342786B2Jul 9, 2019
P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD
FULCRUM THERAPEUTICS INC4 citations68
US12109198B2Oct 8, 2024
Macrocyclic azolopyridine derivatives as EED and PRC2 modulators
FULCRUM THERAPEUTICS INC0 citations59
US11479770B2Oct 25, 2022
Use of p38 inhibitors to reduce expression of DUX4
FULCRUM THERAPEUTICS INC0 citations57
US11291659B2Apr 5, 2022
P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD
FULCRUM THERAPEUTICS INC0 citations57
BOY KENNETH M
4 patentsUS8637525B2Jan 28, 2014
Compounds for the reduction of beta-amyloid production
BOY KENNETH M39 citations92
US8486952B2Jul 16, 2013
Compounds for the reduction of β-amyloid production
BOY KENNETH M34 citations91
US8637523B2Jan 28, 2014
Compounds for the reduction of beta-amyloid production
BOY KENNETH M2 citations61
US8710061B2Apr 29, 2014
Compounds for the reduction of β-amyloid production
BOY KENNETH M0 citations40